Carey Farquhar, MD, MPH

Professor, Departments of Medicine, Epidemiology and Global Health

 

Dr. Carey Farquhar, MD, MPH, received her MD at Harvard Medical School. She completed a residency and chief residency in internal medicine and a fellowship in infectious disease at the University of Washington, where she also earned a Masters in Public Health. She currently spends approximately 2 months each year in Nairobi and Kisumu mentoring US and Kenyan trainees and conducting research on HIV-discordant couples, HIV partner services, correlates of immunity against HIV-1, and mother-to-child HIV-1 transmission. Ongoing studies explore the provision of partner notification and HIV testing services in a cluster-randomized trial of 18 voluntary counseling and testing sites in Kenya and examine home-based education and HIV testing for male partners of pregnant women. The latter is a randomized clinical trial assessing maternal and child health outcomes that is taking place in Kisumu, Kenya. She has published more than 150 peer-reviewed papers and is the Director of two international training programs (listed above) as well as the UW Internal Medicine Global Health Pathway. Dr. Farquhar teaches 3 courses in the School of Public Health -- AIDS: A Multidisciplinary Approach, the Responsible Conduct of International Research, and the Integrated Residency Global Health Leadership course. In addition, she sees HIV-infected patients one half-day per week at Madison Clinic and attends in the Infectious Disease clinic and on the wards at Harborview Medical Center.

Publications

  1. Offorjebe, OA, Ochola, E, Ngila, B, Kinuthia, J, Waweru, H, Bukusi, D et al.. Eligibility and Acceptability of Same-Day HIV Pre-Exposure Prophylaxis Initiation During Emergency Care Encounters in Nairobi, Kenya: A Cross-Sectional Study. J Acquir Immune Defic Syndr. 2026; :. doi: 10.1097/QAI.0000000000003911. PubMed PMID:42357991 .
  2. Rosen, JG, Offorjebe, OA, Ngila, B, Kinuthia, J, Waweru, H, Bukusi, D et al.. Anticipated Determinants and Strategies Supporting Same-Day HIV Pre-Exposure Prophylaxis Implementation During Emergency Care Encounters in Kenya: A Qualitative Study. J Acquir Immune Defic Syndr. 2026; :. doi: 10.1097/QAI.0000000000003910. PubMed PMID:42331025 .
  3. Mbogo, LW, Boyce, CL, Sambai, B, Hawes, SE, Guthrie, BL, Min, WSD et al.. HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya. medRxiv. 2026; :. doi: 10.64898/2026.02.26.26347230. PubMed PMID:41867239 PubMed Central PMC13004105.
  4. Smith-Sreen, J, Timothy, B, Ngila, B, Maina, JW, Pirirei, S, Kinuthia, J et al.. Acceptability and use determinants of digital health technologies for HIV services: a qualitative study of emergency care patients in Nairobi, Kenya. Front Digit Health. 2025;7 :1697814. doi: 10.3389/fdgth.2025.1697814. PubMed PMID:41657956 PubMed Central PMC12876169.
  5. Otieno, G, Masyuko, S, Roy Paladhi, U, Kariithi, E, Sharma, M, Kingston, H et al.. Improving HIV assisted partner services outcomes by eliciting additional partners after the initial encounter. PLOS Glob Public Health. 2026;6 (2):e0004406. doi: 10.1371/journal.pgph.0004406. PubMed PMID:41632741 PubMed Central PMC12867224.
Search PubMed